Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate.
AffiliationJoint Department of Physics, Institute of Cancer Research and Royal Marsden NHS Trust, Sutton, Surrey SM2 5PT, UK.
MetadataShow full item record
AbstractBACKGROUND AND PURPOSE: This paper discusses the application of artificial neural networks (ANN) in predicting biological outcomes following prostate radiotherapy. A number of model-based methods have been developed to correlate the dose distributions calculated for a patient receiving radiotherapy and the radiobiological effect this will produce. Most widely used are the normal tissue complication probability and tumour control probability models. An alternative method for predicting specific examples of tumour control and normal tissue complications is to use an ANN. One of the advantages of this method is that there is no need for a priori information regarding the relationship between the data being correlated. PATIENTS AND METHODS: A set of retrospective clinical data from patients who received radical prostate radiotherapy was used to train ANNs to predict specific biological outcomes by learning the relationship between the treatment plan prescription, dose distribution and the corresponding biological effect. The dose and volume were included as a differential dose-volume histogram in order to provide a holistic description of the available data. RESULTS: It was shown that the ANNs were able to predict biochemical control and specific bladder and rectum complications with sensitivity and specificity of above 55% when the outcomes were dichotomised. It was also possible to analyse information from the ANNs to investigate the effect of individual treatment parameters on the outcome. CONCLUSION: ANNs have been shown to learn something of the complex relationship between treatment parameters and outcome which, if developed further, may prove to be a useful tool in predicting biological outcomes.
CitationUse of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate. 2004, 71 (1):3-12 Radiother Oncol
JournalRadiotherapy and Oncology
- Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
- Authors: Tucker SL, Dong L, Cheung R, Johnson J, Mohan R, Huang EH, Liu HH, Thames HD, Kuban D
- Issue date: 2004 Dec 1
- Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
- Authors: Vargas C, Yan D, Kestin LL, Krauss D, Lockman DM, Brabbins DS, Martinez AA
- Issue date: 2005 Sep 1
- Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer.
- Authors: Tucker SL, Cheung R, Dong L, Liu HH, Thames HD, Huang EH, Kuban D, Mohan R
- Issue date: 2004 Jun 1
- Late rectal bleeding after 3D-CRT for prostate cancer: development of a neural-network-based predictive model.
- Authors: Tomatis S, Rancati T, Fiorino C, Vavassori V, Fellin G, Cagna E, Mauro FA, Girelli G, Monti A, Baccolini M, Naldi G, Bianchi C, Menegotti L, Pasquino M, Stasi M, Valdagni R
- Issue date: 2012 Mar 7
- Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.
- Authors: Zapatero A, García-Vicente F, Modolell I, Alcántara P, Floriano A, Cruz-Conde A, Torres JJ, Pérez-Torrubia A
- Issue date: 2004 Aug 1